Release date: 2015-11-26 The National Statistical Office, the Ministry of Science and Technology, and the Ministry of Finance jointly released the "2014 National Science and Technology Funds Statistics Bulletin", showing that the intensity of China's R&D expenditure in 2014 (the ratio of R&D expenditure to GDP) was 2.05%, compared with the previous year. Increase by 0.04 percentage points. China's R&D investment intensity has exceeded 2% for two consecutive years and is on a continuous upward trend. According to the communique, in 2014, the total investment in R&D expenditure in China was 130.56 billion yuan, an increase of 116.9 billion yuan or 9.9% over the previous year. According to the types of activities, the national expenditure on basic research was 61.35 billion yuan, up 10.6% over the previous year; the application research expenditure was 139.85 billion yuan, up 10.2%; the experimental development expenditure was 110.36 billion yuan, up 9.8%. Basic research, applied research, and experimental development accounted for 4.7%, 10.8%, and 84.5% of total research and experimental development (R&D) expenditures, respectively. According to the main activity subjects, the expenditures of various enterprises were 100.06 billion yuan, up 10.9% over the previous year; the government expenditures of research institutions were 196.22 billion yuan, up 8.1%; the expenditures of higher education institutions were 89.81 billion yuan, up 4.8%. The proportion of expenditures of enterprises, government-owned research institutions and institutions of higher learning was 77.3%, 14.8% and 6.9% respectively. “The contribution of enterprises to the growth of R&D expenditures in the whole society was 84.2%, an increase of 4.5 percentage points over the previous year, and the leading role in the growth of R&D expenditures was further highlighted.†Guan Xiaojing, senior statistician of the Department of Social Sciences of the National Bureau of Statistics, explained the communique. She said that China is the second largest technology investment country in the world after the United States. Although there is still a gap between the R&D investment intensity and the level of 3% to 4% in developed countries, it is increasing year by year. Source: Xinhua News Agency
Bolus, Powders, Injections and other dosage forms for animal use.
Veterinary medicine is informally as old as the human/animal bond but
in recent years has expanded exponentially because of the availability
of advanced diagnostic and therapeutic techniques for most species.
Veterinary drugs used properly, medications are a safe way to keep
animals in good condition while preventing the spread of disease to
other animals and neighbouring herds or flocks. They help to prevent
costly losses to agricultural producers.
Veterinary products list
PRODUCT NAME
CAS NUMBER
SPEVIFICATION
Vet Products,Veterinary Drugs,Veterinary Formula,Veterinary Pharmaceuticals NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com
ProcainePenicillin+Dihydrostreptomycin sulfate
Powder for inj. 0.5G
50Vials/Box
Lysozyme
Inj. 80000IU
10Vials/Box
Diminazene acetruate+antipyretic
For inj. 23.6G
10Vials/Box
Ceftiofur Sodium
For Inj. 0.5G,1.0G
1`s/Box
Dihydrostreptomycin Sulfate for inj.
For Inj. 0.45Mega
1`s/Box
Oxytrtracycline injection
5% ,10% 50ml, 100ml
1`s/Box
Ivermectin injection
1%50ml, 200m
1`s/Pack
Gentamycin Sulfate injection
10%, 100ml
1`s/Box
Levamisole injection
5%, 10% 100ml
1`s/Box
Dextriferron injection
5%, 10%, 100ml
1`s/Box
Tylosin injection
5%, 10%, 100ml
1`s/Box
Enrofloxacin injection
2.5%, 10%, 100ml
1`s/Box
Closantel Sodium injection
5%, 100ml
1`s/Box
Florfenicol Injection
20%, 30%, 100ml
1`s/Box
Sodium selemite and vitamin E inj.
0.1%+5%, 100ml
1`s/Box
VAD3E inj.
100ml
1`s/Box
Amitraz Drench
12.5% 100ml
1`s/Box
Albendazole Suspension
2.5%, 100ml
1`s/Box
Toltrazuril Oral Solution
2.5% 100ml
1`s/Box
Flumequine Solution
10% 100ml
1`s/Box
Albendazole Bolus
150mg,250mg,600mg,1.5g
5`sx10/Box
Levamisole Bolus
150mg, 300mg
5`sx10/Box